Safety and feasibility of implantable, uni-directional planar low-dose rate (LDR) brachytherapy in borderline resectable pancreatic adenocarcinoma. (2020) - Peters, H.; Mosquera, C.; Dault, J.; Todor, D.; Fields, E.; Kaplan, B.